Search Results - "Landry, Kara"

Neuromuscular complications of immune checkpoint inhibitor therapy by Kolb, Noah A., Trevino, Christopher R, Waheed, Waqar, Sobhani, Fatemeh, Landry, Kara K., Thomas, Alissa A., Hehir, Mike

“…ABSTRACT Immune checkpoint inhibitor (ICPI) therapy unleashes the body's natural immune system to fight cancer. ICPIs improve overall cancer survival, however,…”
Get full text

Nivolumab‐Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy by Gergi, Mansour, Landry, Kara K., Ades, Steven, Barry, Maura, Zakai, Neil A., Herrera, Diego Adrianzen

“…Thrombotic thrombocytopenic purpura (TTP) is a rare but life‐threatening microangiopathic hemolytic anemia characterized by thrombocytopenia, hemolytic anemia,…”
Get full text

Erratum to: Early gastric adenocarcinoma arising within foveolar-type dysplasia in a patient with Muir-Torre variant Lynch syndrome by McKnight, Tristan F. P., Noffsinger, Amy E., Landry, Kara K., Ahmed, Ovais, Wilcox, Rebecca

Get full text

Early gastric adenocarcinoma arising within foveolar-type dysplasia in a patient with Muir-Torre variant Lynch syndrome by McKnight, Tristan F.P., Noffsinger, Amy E., Landry, Kara K., Ahmed, Ovais, Wilcox, Rebecca

Get full text

Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis by Landry, Kara K, Lyon, Jessica L, Victoria, Kitty E, Changizzadeh, P Nick, Cole, Bernard F, Pulluri, Bhargavi, Sikov, William M, Wood, Marie E

“…Adding carboplatin to weekly paclitaxel as part of neoadjuvant chemotherapy (NACT) for stage II-III triple negative breast cancer (TNBC) has been shown to…”
Get full text

N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort by Judd, Suzanne E., Kleindorfer, Dawn O., Howard, George, Howard, Virginia J., Zakai, Neil A., Cushman, Mary, Landry, Kara K.

“…N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), a commonly used clinical marker of cardiac function, is associated with the presence of stroke symptoms…”
Get full text

Caplacizumab treatment for acquired refractory thrombotic thrombocytopenic purpura by Khan, Sundas, Landry, Kara, Umyarova, Elvira

Get full text

Predictors of use of prevention strategies among women at high-risk for breast cancer by Landry, Kara, Tuo, Ya, Levine, Emma, Srikureja, Anya, Wood, Marie

“…10554 Background: Uptake of chemoprevention and prophylactic surgery among women at high risk for breast cancer is low, despite proven efficacy. We evaluated…”
Get full text

Neurological Complications of CAR T Cell Therapy by Landry, Kara, Thomas, Alissa A.

“…Purpose of Review Chimeric antigen receptor (CAR) T cells are a breakthrough therapeutic treatment for patients with relapsed and refractory hematologic…”
Get full text

Abstract PS5-11: Prospective HER-2 testing using simultaneous immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH): Experience of dual testing in a single academic institution by Landry, Kara K, Ambaye, Abiy B, Weaver, Donald L, Kaufman, Peter A

“…Abstract Background: HER-2 testing informs prognosis and critically guides therapy in breast cancer. Current guidelines for immunohistochemistry (IHC) testing…”
Get full text

Abstract PO4-26-05: Dual HER2 Testing With Both Immunohistochemistry (IHC) and ISH (In Situ Hybridization): Long Term Analysis of Dual Testing in a Single Academic Institution by Xu, Xiaocao, Ambaye, Abiy, Landry, Kara, Kaufman, Peter

“…Abstract Background: HER-2 critically guides therapies and is prognostic in breast cancer (BC). Current ASCO/CAP guidelines for immunohistochemistry (IHC)…”
Get full text

Panel Testing for Hereditary Breast Cancer: More or Less? by Landry, Kara K., Wood, Marie E.

“…Purpose of Review Panel testing is increasingly being offered to patients. Currently, women may be offered a panel of up to 80 genes. Oncologists are tasked…”
Get full text

Eliminating barriers to uptake of germline genetic testing for patients with advanced cancer: The GTAC study by Landry, Kara K., Feldman, Heather M, Nowak, Sarah A, Taylor, Hannah L, Johns, Marie, McKinnon, Wendy, Colello, Laura S, Nielsen, Sarah M., Esplin, Edward D., Greenblatt, Marc, Wood, Marie

“…10617 Background: Identification of pathogenic germline variants (PGVs) is important in guiding treatment decisions, cancer screening and testing of family…”
Get full text

Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients by Landry, Kara K., DeSarno, Michael, Kipnis, Lindsay, Barquet Ramos, Farid, Breen, Katelyn, Patton, Kaleigh, Morrissette, Audrey, Buehler, Ryan, Ukaegbu, Chinedu, Rohanizadegan, Mersedeh, Yurgelun, Matthew B., Syngal, Sapna, Rana, Huma Q., Garber, Judy Ellen

“…10523 Background: Broad-based germline multi-gene panel testing (MGPT) for inherited predisposition has become increasingly common for cancer patients. Both…”
Get full text

Abstract MP02: N-Terminal Pro-B-type Natriuretic Peptide and Risk of Stroke in Those With and Without Cerebrovascular Disease: The REGARDS Cohort by Landry, Kara, Judd, Suzanne, Kleindorfer, Dawn, Howard, George, Howard, Virginia, Zakai, Neil, Cushman, Mary

“…Abstract only Background: N-terminal pro-B-type natriuretic peptide (NT-pro-BNP), a commonly used marker of cardiac function, is associated with presence of…”
Get full text

Investigation of discordant sibling pairs from hereditary breast cancer (HBC) families by Landry, Kara, Seward, David, Dragon, Julie, McKinnon, Wendy, Colello, Laura S, Sweasy, Joann, Wallace, Susan, Cuke, Melissa, Wood, Marie

“…Abstract only…”
Get full text

Non-BRCA hereditary gene mutations and breast cancer phenotype: An ISC-RAM Consortia study by Arun, Banu, Schnabel, Freya Ruth, Chun, Jennifer, Heeke, Arielle Lutterman, Smith, Julia Anne, Roses, Daniel F., Kurz, Emma, Landry, Kara, Gutierrez Barrera, Angelica, Wood, Marie, Isaacs, Claudine

“…Abstract only…”
Get full text

Caplacizumab treatment for acquired refractory thrombotic thrombocytopenic purpura by Khan, Sundas, Landry, Kara, Umyarova, Elvira

Get full text